ENST00000370695.8:c.25G>T

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BA1BP4

This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Ala9Ser variant in SLC9A6 is 0.307% in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). Computational analysis prediction tools suggest that the p.Ala9Ser variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Ala9Ser variant in SLC9A6 is classified as benign based on the ACMG/AMP criteria (BA1, BP4). LINK:https://erepo.genome.network/evrepo/ui/classification/CA295170/MONDO:0010278/016

Frequency

Genomes: 𝑓 0.0034 ( 1 hom., 107 hem., cov: 22)
Exomes 𝑓: 0.0045 ( 9 hom. 1447 hem. )

Consequence

SLC9A6
ENST00000370695.8 missense

Scores

1
15

Clinical Significance

Benign reviewed by expert panel B:10

Conservation

PhyloP100: 2.12
Variant links:
Genes affected
SLC9A6 (HGNC:11079): (solute carrier family 9 member A6) This gene encodes a sodium-hydrogen exchanger that is amember of the solute carrier family 9. The encoded protein localizes to early and recycling endosomes and may be involved in regulating endosomal pH and volume. Defects in this gene are associated with X-linked syndromic cognitive disability, Christianson type. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC9A6NM_001379110.1 linkc.-57+50G>T intron_variant Intron 1 of 17 ENST00000630721.3 NP_001366039.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC9A6ENST00000370695.8 linkc.25G>T p.Ala9Ser missense_variant Exon 1 of 16 1 ENSP00000359729.4 Q92581-2
SLC9A6ENST00000370698.7 linkc.25G>T p.Ala9Ser missense_variant Exon 1 of 16 1 ENSP00000359732.3 Q92581-1
SLC9A6ENST00000630721.3 linkc.-57+50G>T intron_variant Intron 1 of 17 4 NM_001379110.1 ENSP00000487486.2 A0A0D9SGH0
SLC9A6ENST00000370701.6 linkc.-57+50G>T intron_variant Intron 1 of 16 1 ENSP00000359735.1 Q92581-3

Frequencies

GnomAD3 genomes
AF:
0.00339
AC:
377
AN:
111153
Hom.:
1
Cov.:
22
AF XY:
0.00321
AC XY:
107
AN XY:
33375
show subpopulations
Gnomad AFR
AF:
0.000653
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00103
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000377
Gnomad FIN
AF:
0.00603
Gnomad MID
AF:
0.00424
Gnomad NFE
AF:
0.00571
Gnomad OTH
AF:
0.00469
GnomAD3 exomes
AF:
0.00289
AC:
250
AN:
86554
Hom.:
1
AF XY:
0.00326
AC XY:
47
AN XY:
14414
show subpopulations
Gnomad AFR exome
AF:
0.000776
Gnomad AMR exome
AF:
0.000874
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00779
Gnomad NFE exome
AF:
0.00480
Gnomad OTH exome
AF:
0.00445
GnomAD4 exome
AF:
0.00452
AC:
4606
AN:
1019726
Hom.:
9
Cov.:
30
AF XY:
0.00452
AC XY:
1447
AN XY:
320406
show subpopulations
Gnomad4 AFR exome
AF:
0.000549
Gnomad4 AMR exome
AF:
0.00106
Gnomad4 ASJ exome
AF:
0.000126
Gnomad4 EAS exome
AF:
0.0000365
Gnomad4 SAS exome
AF:
0.000243
Gnomad4 FIN exome
AF:
0.00828
Gnomad4 NFE exome
AF:
0.00512
Gnomad4 OTH exome
AF:
0.00378
GnomAD4 genome
AF:
0.00339
AC:
377
AN:
111193
Hom.:
1
Cov.:
22
AF XY:
0.00320
AC XY:
107
AN XY:
33427
show subpopulations
Gnomad4 AFR
AF:
0.000651
Gnomad4 AMR
AF:
0.00103
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000378
Gnomad4 FIN
AF:
0.00603
Gnomad4 NFE
AF:
0.00571
Gnomad4 OTH
AF:
0.00463
Alfa
AF:
0.00216
Hom.:
14
Bravo
AF:
0.00278
ExAC
AF:
0.00263
AC:
297

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:4
Mar 21, 2016
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 23, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 06, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:3
Apr 18, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 13, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Christianson syndrome Benign:2
Mar 26, 2021
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel
Significance: Benign
Review Status: reviewed by expert panel
Collection Method: curation

The allele frequency of the p.Ala9Ser variant in SLC9A6 is 0.307% in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). Computational analysis prediction tools suggest that the p.Ala9Ser variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Ala9Ser variant in SLC9A6 is classified as benign based on the ACMG/AMP criteria (BA1, BP4). -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Jul 18, 2016
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
14
DANN
Benign
0.95
DEOGEN2
Benign
0.095
.;T
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.59
T;T
MetaRNN
Benign
0.0053
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L;L
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-0.23
N;N
REVEL
Benign
0.037
Sift
Benign
0.11
T;T
Sift4G
Benign
0.75
T;T
Polyphen
0.0
B;B
Vest4
0.20
MVP
0.15
MPC
0.95
ClinPred
0.0036
T
GERP RS
2.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.068
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201523857; hg19: chrX-135067686; COSMIC: COSV65789170; COSMIC: COSV65789170; API